Correlation Between Aerovate Therapeutics and Tff Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Tff Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Tff Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Tff Pharmaceuticals, you can compare the effects of market volatilities on Aerovate Therapeutics and Tff Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Tff Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Tff Pharmaceuticals.
Diversification Opportunities for Aerovate Therapeutics and Tff Pharmaceuticals
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and Tff is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Tff Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tff Pharmaceuticals and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Tff Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tff Pharmaceuticals has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Tff Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Tff Pharmaceuticals
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.83 times more return on investment than Tff Pharmaceuticals. However, Aerovate Therapeutics is 1.2 times less risky than Tff Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Tff Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 1,665 in Aerovate Therapeutics on August 31, 2024 and sell it today you would lose (1,402) from holding Aerovate Therapeutics or give up 84.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Tff Pharmaceuticals
Performance |
| Timeline |
| Aerovate Therapeutics |
| Tff Pharmaceuticals |
Aerovate Therapeutics and Tff Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Tff Pharmaceuticals
The main advantage of trading using opposite Aerovate Therapeutics and Tff Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Tff Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will offset losses from the drop in Tff Pharmaceuticals' long position.| Aerovate Therapeutics vs. Cue Biopharma | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Molecular Partners AG |
| Tff Pharmaceuticals vs. Cue Biopharma | Tff Pharmaceuticals vs. Eliem Therapeutics | Tff Pharmaceuticals vs. Inhibrx | Tff Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |